bluebird bio Eulerpool News

bluebird bio Stock News

bluebird bio is being monitored by journalists and investors worldwide. We gather the latest bluebird bio news here.

• December 29 ·

  Yahoo
  bluebird bio, Inc. (BLUE): Is This Gene Therapy Stock a Good Buy Right Now?
• December 8 ·

  Yahoo
  bluebird bio Presents Positive Long-Term Data On LYFGENIA™ (lovotobegligene autotemcel) Gene Therapy for Sickle Cell Disease at 66th American Society of Hematology (ASH) Annual Meeting and Exposition
• December 7 ·

  Yahoo
  Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
• December 4 ·

  Yahoo
  bluebird bio Announces 1-for-20 Reverse Stock Split
• December 4 ·

  Yahoo
  bluebird bio Confirms Participation in Center for Medicare and Medicaid Innovation (CMMI) Cell and Gene Therapy Access Model
• November 29 ·

  Yahoo
  FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy
• November 20 ·

  SeekingAlpha
  My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys
• November 16 ·

  Yahoo
  bluebird bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
• November 15 ·

  Yahoo
  JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
• November 15 ·

  Yahoo
  bluebird bio Inc (BLUE) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...